Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

    Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    Start listeningView podcast show

    Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    ratings:
    Length:
    17 minutes
    Released:
    Feb 15, 2024
    Format:
    Podcast episode

    Description

    In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospect of GLP-1 RA-based therapies in type 1 diabetes, and the potential roles for tirzepatide beyond T2D and weight management.

    Episode Highlights
    00:00 - Intro
    01:56 - Use of GLP-1s in T1D
    05:32 - Study on Tirzepatide in T1D 
    10:04 - Insulin Use in Study
    11:20 - Safety Outcomes
    Released:
    Feb 15, 2024
    Format:
    Podcast episode

    Titles in the series (94)

    Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at http://HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.